AIxCrypto Holdings reported its first full-year results after transforming from a biotech firm to an AI and blockchain infrastructure company. The company completed a $41.0 million PIPE financing, rebranded, and began Nasdaq trading in November 2025. Financial results show approximately $31 million in total assets, $19 million in cash, and platform metrics of over 5.8 million registered wallets.
HCW Biologics regained compliance with Nasdaq listing rules and completed a follow-on offering priced at $0.6055 per unit to raise approximately $1.5 million for clinical development of immunotherapies targeting chronic inflammation.